159 related articles for article (PubMed ID: 36695982)
1. Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Kumagai K; Yamada T; Terashima M; Yabusaki H; Nishikawa K; Tanabe K; Yunome G; Kawachi Y; Yamada T; Fukagawa T; Kinoshita T; Watanabe M; Ishiyama K; Inoue K; Boku N
Gastric Cancer; 2023 Mar; 26(2):307-316. PubMed ID: 36695982
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
3. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
[TBL] [Abstract][Full Text] [Related]
5. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
6. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
[TBL] [Abstract][Full Text] [Related]
7. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
Hwang JE; Kim H; Shim HJ; Bae WK; Hwang EC; Jeong O; Ryu SY; Park YK; Cho SH; Chung IJ
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2157-2166. PubMed ID: 31273512
[TBL] [Abstract][Full Text] [Related]
8. The impact and optimal indication of non-curative gastric resection for stage IV advanced gastric cancer diagnosed during surgery: 10 years of experience at a single institute.
Yamada N; Akai A; Nomura Y; Tanaka N
World J Surg Oncol; 2016 Mar; 14():79. PubMed ID: 26965446
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with gastric cancer and solitary lymph node metastasis.
Chen CQ; Wu XJ; Yu Z; Bu ZD; Zuo KQ; Li ZY; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8611-8. PubMed ID: 24379578
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
12. Negative lymph node count as an independent prognostic factor in stage III patients after curative gastrectomy: A retrospective cohort study based on a multicenter database.
Zhang N; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
Int J Surg; 2020 Feb; 74():44-52. PubMed ID: 31874262
[TBL] [Abstract][Full Text] [Related]
13. Analysis of risk factors of stage IV gastric cancer from the SEER database.
Ge XY; Ge F; Wang Z; Wang YL; Lei LW; Liu QR; Sun XY; Jiang X
Ann R Coll Surg Engl; 2020 May; 102(5):355-362. PubMed ID: 32326735
[TBL] [Abstract][Full Text] [Related]
14. Impact of the anatomical location and the number of metastatic lymph nodes on gastric cancer patient´s survival.
Duchon R; Bernadic M; Pindak D
Bratisl Lek Listy; 2020; 121(4):253-258. PubMed ID: 32356438
[TBL] [Abstract][Full Text] [Related]
15. Curative-Intent Surgery for Stage IV Advanced Gastric Cancer: Who Can Undergo Surgery and What Are the Prognostic Factors for Long-Term Survival?
Sato S; Kunisaki C; Tanaka Y; Sato K; Miyamoto H; Yukawa N; Kosaka T; Akiyama H; Endo I; Misumi T
Ann Surg Oncol; 2019 Dec; 26(13):4452-4463. PubMed ID: 31529308
[TBL] [Abstract][Full Text] [Related]
16. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
[TBL] [Abstract][Full Text] [Related]
17. Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan.
Lee JH; Paik YH; Lee JS; Song HJ; Ryu KW; Kim CG; Park SR; Kook MC; Kim YW; Bae JM
Ann Surg Oncol; 2006 Sep; 13(9):1163-7. PubMed ID: 16952027
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
19. Risks and benefits of additional surgery for early gastric cancer in the upper third of the stomach meeting non-curative resection criteria after endoscopic submucosal dissection.
Park SH; Yoon HM; Ryu KW; Kim YW; Kook MC; Eom BW
World J Surg Oncol; 2022 Sep; 20(1):311. PubMed ID: 36155115
[TBL] [Abstract][Full Text] [Related]
20. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.
Gu P; Deng J; Sun Z; Wang Z; Wang W; Liang H; Xu H; Zhou Z
Surg Today; 2021 Jan; 51(1):101-110. PubMed ID: 32754844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
